
In 2023 and 2024, the American Academy of Dermatology published guidelines on the use of topical and systemic therapies for the management of atopic dermatitis (AD) in adults. Since the publication of these guidelines, several novel therapies have emerged to treat AD. To update previous guidelines on...

Glioblastoma (GBM) is a highly aggressive and lethal brain tumor characterized by inevitable recurrence and resistance to standard therapies such as radiotherapy and temozolomide (TMZ) [1, 2–3]. Even after maximal surgical resection and chemoradiation, GBM tumors often relapse within the irradiated...

Acne vulgaris (AV) is a common dermatological skin disorder. When other treatments for severe cystic AV have failed, isotretinoin (13-cis-retinoic acid) is preferred. Isotretinoin is a first-generation nonaromatic b-carotene retinoid (provitamin A) [1]. Oral isotretinoin results in long-term acne remission...

Acne vulgaris is a chronic skin condition of the pilosebaceous unit with a multifactorial and intricate pathophysiology that includes increased sebum production, androgenic hormonal effects, follicular hyperkeratinization, and bacterial hyperproliferation [1, 2–3]. Acne lesions may range from mild,...

Given that the product of glucosylceramide (GlcCer) catabolism is ceramide, it is reasonable to assume that cells will produce less ceramide in Gaucher disease (GD), as GlcCer catabolism is impaired by defective acid beta-glucocerebrosidase (GCase) activity. However, ceramide is also generated from the...